ADMA BIOLOGICS, INC. Adjustments to Additional Paid in Capital, Other
ADMA BIOLOGICS, INC. (ADMA) reported Adjustments to Additional Paid in Capital, Other of $0 for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-06.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2020-08-05
- ADMA BIOLOGICS, INC. adjustments to additional paid in capital, other for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- ADMA BIOLOGICS, INC. adjustments to additional paid in capital, other for the quarter ending 2019-09-30 was $0.00.
- ADMA BIOLOGICS, INC. adjustments to additional paid in capital, other for the quarter ending 2019-06-30 was $879.91K.
- ADMA BIOLOGICS, INC. adjustments to additional paid in capital, other for the quarter ending 2019-03-31 was $2.70M.
| Period end | Adjustments to Additional Paid in Capital, Other 1 month | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|---|---|
| 2020-03-31 | $0.00 10-Q · filed 2020-05-06 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $879.91K derived: sum of 2 quarters · filed 2020-08-05 | $3.58M 10-Q · filed 2019-11-06 | ||
| 2019-06-30 | $879.91K 10-Q · filed 2020-08-05 | $3.58M 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | $2.70M 10-Q · filed 2020-08-05 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | |||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-08 | ||||
| 2011-12-31 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-01 | $17.58K 10-Q · filed 2012-02-01 | |||
| 2011-09-30 | $2.58K 10-Q · filed 2011-10-28 | ||||
| 2011-06-30 | $25.50K 10-Q · filed 2012-02-01 | ||||
| 2010-06-30 | $23.00K 10-Q · filed 2012-02-01 | ||||
| 2009-06-30 | $30.50K 10-Q · filed 2012-02-01 | ||||
| 2008-06-30 | $7.00K 10-Q · filed 2012-02-01 | ||||
| 2007-06-30 | $12.50K 10-Q · filed 2012-02-01 | ||||
| 2006-06-30 | $40.00K 10-Q · filed 2012-02-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |